Skip to content

JNJ vs SHW: Dividend Comparison

JNJ$278.81
Johnson & Johnson
Health Care
vs
SHW$346.80
Sherwin Williams Co
Materials

Dividend data as of

Johnson & Johnson (JNJ) from Health Care and Sherwin Williams Co (SHW) from Materials offer different dividend profiles for income-focused portfolios. JNJ edges ahead on yield at 1.90% versus SHW's 0.92%. For dividend growth, SHW leads with a 5-year CAGR of 7.8% versus JNJ's 5.0%. SHW holds the edge in dividend safety with a "Safe" rating. JNJ is a Dividend King while SHW is a Dividend Aristocrat.

Verdict

Best for Income
JNJ
Higher yield at 1.90%
Best for Growth
SHW
5yr CAGR of 7.8%
Best for Safety
SHW
Rated "Safe"

Track JNJ and SHW in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan (1 portfolio, 10 holdings).

30-day free brokerage sync trial. No credit card. Then from $9.99/month. Choosing a tracker? See the best dividend trackers compared.

Metric
Price
$278.81
$346.80
Dividend Yield
1.90%
0.92%
Annual Dividend
$5.36
$3.20
5yr Div CAGR
5.0%
7.8%
3yr Div CAGR
4.4%
9.8%
Consecutive Years
61
39
Payout Ratio
80.12%
29.35%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$190/yr
$92/yr

Yield Analysis

JNJ
1.90%
SHW
0.92%

JNJ yields 0.98% more than SHW. In dollar terms, JNJ pays $5.36/share vs SHW's $3.20/share annually.

Dividend Growth

JNJ 5yr CAGR
5.0%
decelerating
SHW 5yr CAGR
7.8%
accelerating

JNJ: Dividend growth is slowing — the 3-year CAGR of 4.4% trails the 5-year rate of 5.0% and the 10-year rate of 5.3%.

SHW: Dividend growth is accelerating — the 3-year CAGR of 9.8% exceeds the 5-year rate of 7.8% and the 10-year rate of 11.1%.

Dividend Safety

JNJ
At Risk
Payout Ratio80%
SHW
Safe
Payout Ratio29%

JNJ: The payout ratio of 80% is elevated, which may indicate the dividend could be cut if earnings decline. Earnings cover the dividend 1.2x.

SHW: The payout ratio of 29% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 3.4x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
JNJ
SHW
$10,000
$190/yr
$92/yr
$50,000
$949/yr
$458/yr
$100,000
$1,897/yr
$917/yr

What does $10,000 buy in JNJ vs SHW today?

At $278.81 per share, $10,000 buys about 35.9 shares of Johnson & Johnson (JNJ). Each share pays $5.36 per year in dividends, so the position starts out generating roughly $192 per year — about $16 a month.

At $346.80 per share, $10,000 buys about 28.8 shares of Sherwin Williams Co (SHW). Each share pays $3.20 per year in dividends, so the position starts out generating roughly $92 per year — about $8 a month.

JNJ is the larger income stream from day one: $100 per year more on the same $10,000 invested.

What could $10,000 of JNJ or SHW income look like in 10 years?

Johnson & Johnson (JNJ) has raised its dividend about 5.0% a year over the past five years. If that pace held, the $190 per year that $10,000 generates today at the current 1.90% yield would reach $308 per year by 2036 — a 3.1% yield on the original cost.

Sherwin Williams Co (SHW) has raised its dividend about 7.8% a year over the past five years. If that pace held, the $92 per year that $10,000 generates today at the current 0.92% yield would reach $194 per year by 2036 — a 1.9% yield on the original cost.

On those trailing rates, JNJ pays more in 2036: $308 versus $194 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would SHW's dividend growth overtake JNJ's higher yield?

Sherwin Williams Co (SHW) yields less today (0.92% vs 1.90%) but has grown its dividend faster — 7.8% vs 5.0% a year over the past five years. If both trends continued, a $10,000 position in SHW would start out-earning the same position in JNJ around 2054 (roughly 28 years from now), paying about $747 per year at the crossover. Before that point, JNJ pays more each year; after it, the gap compounds in SHW's favor.

Can JNJ and SHW afford their dividends?

Johnson & Johnson (JNJ) earns $6.59 per share against $5.36 paid out in dividends — 1.2x coverage (a 80% payout ratio).

Sherwin Williams Co (SHW) earns $10.87 per share against $3.20 paid out in dividends — 3.4x coverage (a 29% payout ratio).

SHW's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for JNJ if earnings weaken.

Which fits an early-retirement income portfolio better, JNJ or SHW?

For income you need right now, Johnson & Johnson (JNJ) leads: $100,000 invested today pays about $158 a month at the current 1.90% yield, versus $76 a month from Sherwin Williams Co (SHW) at 0.92%.

With a decade or more before the income is needed, SHW's faster dividend growth (7.8% vs 5.0% a year) matters more than the starting yield — raises compound into the larger paycheck over time.

On consistency: JNJ has raised its dividend 61 consecutive years; SHW has raised its dividend 39 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $372/yr in JNJ vs $212/yr in SHW by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.